Table 3.
Observed anticonvulsive and neuroprotective actions of novel, potent antioxidants.
Substance | Cells/Animals/Humans | Model | References |
---|---|---|---|
Potential antioxidant actions | |||
Aspalatone | |||
GPx mimetic [202] | |||
|
Animal modelIn vitro ESR study | KA - | [115] [115] |
EUK-134 (new, potent SOD mimetic) | |||
Prevents oxidative stress and reduces neuronal damage [117]
|
In vitro model Animal model |
- KA |
[203] [127] |
|
Animal model | KA | [117, 118] |
MnTBAP | |||
Inhibits mitochondrial oxidative stress and neuronal loss
|
Animal model (rats) | KA | [118-120] |
Tempol | |||
Protects neuronal cells and exerts anticonvulsant effects via:
|
Animal models | KA | [121] |
There were no effects exerted on seizure-like activity in hippocampus | Animal models | KA | [121] |
8-OHdG – 8-hydroxy-2-deoxyguanosine, AP-1 – activator protein, CAT – catalase, DNA – deoxyribonucleic acid, ESR - electron spin resonance, GPx – glutathione peroxidase, GSH – glutathione, MnTBAP – Mn(III)tetrakis (4-benzoic acid) porphyrin, KA – kainic acid, LPO- lipid peroxidation, NF – nuclear factor, SOD - superoxide dismutase.